Proventa International will be gathering over 100 C-Level Directors from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve their key strategic challenges in the area of Clinical Operations.Register Now
The Clinical Operations Roundtable Discussions Strategy Meeting is free to attend for qualified end-users. These include Senior Executives of Clinical Operations (from medium to large Pharma, Biopharma and Biotech players) as well as thought leaders from Academia and regulatory authorities.
Thought leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
– Clinical Operations, Data Sciences, Clinical Outsourcing, Patient Recruitment, eTMF, Safety Data Management, Clinical Trial Management, Data Acquisition Technology and Integrations, Clinical, Pharmacology Scientific Operations, Clinical Informatics and Innovation.
Those who do not qualify for complimentary passes, including vendors, exchanges, consultancies and other service providers, can apply here.
Chief Development and Operations Officer, Karyopharm Therapeutics Inc.
Ran has more than 20 years of experience in the international biopharmaceutical industry encompassing clinical drug development operations activities. Prior to joining Karyopharm Ran Frenkel held a number of senior management roles in Europe, Israel and the United States, most recently as Managing Director EMEA for Clinipace Worldwide, an international clinical research organization, where he had responsibility for the overall management of the organization in Europe, the Middle East and Africa. Prior to joining Clinipace Worldwide, Mr. Frenkel established and managed the Israeli office of PFC Pharma Focus AG, and he held the position of Managing Director at Actelion Pharmaceuticals with responsibility for all science and business affairs of the company in Israel.
Chief Medical Officer, Syndax Phamaceuticals
Chief Technology Officer, Gelesis
Global Head, Strategy and Operations, Clinical Development Quality, Novartis
Vice President, Therapeutics Operations, Moderna Therapeutics
Vice President, Global Clinical Operations, Biogen Idec
Executive Director Outsourcing & Contracts, Medical and Development, Astellas
Her 20+ year career has included a variety of senior roles in partnership operations, contracting, and business support at EMD Serono, PAREXEL, PPD and ClinTrials Research.
In these roles, Charlotte has had the opportunity to collaborate on a global basis with CROs, biotech companies all the way through the largest pharmaceutical companies in the world to support initiatives focused around change management, oversight, business & commercial management, portfolio delivery, and innovation.
Director Head of TMF Operations, Pfizer
Clinical Operations Strategy Meeting US 2017,
The Westin Boston Waterfront
425 Summer St, Boston, MA 02210